Unknown NA INTERVENTIONAL 2-arm NCT05285397

Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

Liraglutide's Effect on Weight Loss in Patients After Secondary Bariatric Surgery ; a Randomized Double-blind Controlled Study.

Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt

Conditions Morbid Obesity

Interventions Liraglutide Pen Injector [Saxenda]

Updated 4 times since 2022 Last updated: Mar 9, 2022 Started: Mar 10, 2022 Primary completion: Sep 30, 2022 Completion: Sep 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Morbid Obesity and is currently ongoing. General Committee of Teaching Hospitals and Institutes, Egypt leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Apr 2022 — Apr 2024 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Committee of Teaching Hospitals and Institutes, Egypt

Data source: General Committee of Teaching Hospitals and Institutes, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt